Molecular Structure (7230fa8a 7cda 458d Baa6 31149a64cd3e 01)
Glycopyrrolate Solution
Product Images NDC 70069-617
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 70069-617). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
20 mL Vial Label (7230fa8a 7cda 458d Baa6 31149a64cd3e 02)
This is the product information for Glycopyrrolate injection, which is for intramuscular or intravenous administration. This drug is available in a 20 mL multiple dose vial and is not for use in newborns. It contains benzyl alcohol and the usual dosage can be found in the package insert. The product is stored at 20°C to 25°C and is manufactured for Somerset Therapeutics, LLC. The item was made in India and has a unique code number. The area for the overprinting of LOT and EXP is required to be blank and varnish free. Unfortunately, the text includes an unreadable code "AMALMWHN -dX3".*
20 mL Carton Label (7230fa8a 7cda 458d Baa6 31149a64cd3e 03)
This is a description of a medication called "Glycopyrrolate Injection, USP" which contains water and benzyl alcohol as a preservative. It comes in a 10x20 ml multiple dose vial and is manufactured for Rx only in the USA. The usual dosage must be consulted in the package insert, and it should be stored at a temperature between 20°C to 25°C (68°F to 77°F). It is to be administered intramuscularly or intravenously.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
